Patent details

EP2155195 Title: Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor

Basic Information

Publication number:
EP2155195
PCT Application Number:
PCT/US/2008/004760
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP087428207
PCT Publication Number:
WO/2008/127682
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor
French Title of Invention:
Combinaison d'une thérapie anticoagulante à un composé agissant en tant qu'inhibiteur de facteur Xa
German Title of Invention:
Gerinnungshemmende Kombinationstherapie mit einer Verbindung, die als Faktor-Xa-Hemmer wirkt
SPC Number:

Dates

Filing date:
11/04/2008
Grant date:
16/07/2014
EP Publication Date:
16/07/2014
PCT Publication Date:
23/10/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/02/2010
EP B1 Publication Date:
16/07/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
11/04/2015
Expiration date:
11/04/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
11/04/2008
 
 

Name:
Millennium Pharmaceuticals Inc.
Address:
40 Landsdowne Street, Cambridge, MA 02139, United States (US)

Inventor

1

Name:
SINHA Uma
Address:
United States (US)

2

Name:
HOLLENBACH Stanley, J.
Address:
United States (US)

3

Name:
ANDRE Patrick
Address:
United States (US)

Priority

Priority Number:
911852 P
Priority Date:
13/04/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/4365;
Filing date Document type Number of pages